Cambridge University Hospital NHS Foundation Trust
Cambridge, United Kingdom
NCT Number: NCT03617848
Heart failure (HF) accounts for 2% of National Health Service (NHS) expenditure, and 5% of emergency hospitalisations. Patients with HF with preserved ejection fraction (HFpEF) are older, have more comorbidities, have similarly poor or worse outcomes compared to patients with reduced ejection fraction (HFrEF), and currently lack an evidence base for treatment. The investigators hypothesise that outcomes of patients with HFpEF can be improved through optimised management and self-management of comorbidities, fluid status and lifestyle delivered in primary care in collaboration with specialists. The primary aim is to develop a programme of optimised management by improving understanding of needs and experiences of patients with HFpEF, clinical decision-making and management in primary care, and integrating research findings with patient and clinical expertise. The main objective for this work package is to identify patients with HFpEF in primary care and assess comorbidities and other factors, management, morbidity and mortality at one year. The methodology employed will be a longitudinal cohort study of 270 patients with HFpEF in primary care followed for 12 months.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Cambridge, United Kingdom
This work package of the study will use phenotyping and one-year follow-up of a community recruited cohort of patients with HFpEF or probable HFpEF to understand the characteristics and needs of this patient group. It involves a longitudinal cohort study conducted to identify patients with HFpEF in primary care and assess comorbidities, lifestyle factors, frailty, self-management, symptoms, quality of life, cognitive function, types of care received, management of risk factors and comorbidities, and one year morbidity and mortality. This will inform particular areas for assessment and management/self-management in the optimised programme. The investigators will also apply to NHS Digital who are the data controllers of Hospital Episode Statistics to check if participants have had any hospitals visits throughout the duration of the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adult patients with diagnosed or suspected HFpEF (defined as: patients diagnosed with non-valvular HF that are i) not diagnosed with left ventricular systolic dysfunction or have a documented ejection fraction < 50%; or ii) do have a reported 'normal' or preserved EF, documented EF > 50%, or reported diastolic dysfunction without moderate to severe systolic dysfunction) who:
Exclusion criteria
Any patients who have:
Time frame: 1 year from recruitment
Episodes of diseases
Time frame: 1 year from recruitment
Confirmed death during follow-up
Time frame: Baseline, 6 & 12 months
Heart failure specific quality of life over time (transformed total score 0 - 100); higher scores indicate better quality of life. 5 point change considered clinically relevant.
Time frame: baseline to 6 & 12 months
physical function changes over time
Time frame: baseline to 6 & 12 months
cognitive function over time
Professor Christi Deaton
Other
Acronym: OPTIMISEHFpEF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887271
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT06576297
Aging, Frailty
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04945707
Anemia, Anemia, Hypochromic
Boston, Massachusetts, United States
View Trial DetailsNCT07599293
Chronic Heart Failure, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details